U.S. markets closed
  • S&P 500

    3,841.47
    -11.60 (-0.30%)
     
  • Dow 30

    30,996.98
    -179.03 (-0.57%)
     
  • Nasdaq

    13,543.06
    +12.15 (+0.09%)
     
  • Russell 2000

    2,168.76
    +27.34 (+1.28%)
     
  • Crude Oil

    51.98
    -1.15 (-2.16%)
     
  • Gold

    1,855.50
    -10.40 (-0.56%)
     
  • Silver

    25.57
    -0.29 (-1.12%)
     
  • EUR/USD

    1.2174
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.0910
    -0.0180 (-1.62%)
     
  • GBP/USD

    1.3684
    -0.0046 (-0.34%)
     
  • USD/JPY

    103.7700
    +0.2650 (+0.26%)
     
  • BTC-USD

    32,933.35
    +398.40 (+1.22%)
     
  • CMC Crypto 200

    651.44
    +41.45 (+6.79%)
     
  • FTSE 100

    6,695.07
    -20.35 (-0.30%)
     
  • Nikkei 225

    28,631.45
    -125.41 (-0.44%)
     

Karuna Therapeutics Inc (KRTX) CFO Troy A. Ignelzi Sold $835,920 of Shares

GuruFocus.com
·1 min read

- By insider

CFO of Karuna Therapeutics Inc (30-Year Financial, Insider Trades) Troy A. Ignelzi (insider trades) sold 8,000 shares of KRTX on 01/08/2021 at an average price of $104.49 a share. The total sale was $835,920.


Karuna Therapeutics Inc has a market cap of $2.91 billion; its shares were traded at around $108.400000 . GuruFocus has detected 1 severe warning sign with Karuna Therapeutics Inc. .

CFO Recent Trades:

  • CFO Troy A. Ignelzi sold 8,000 shares of KRTX stock on 01/08/2021 at the average price of $104.49. The price of the stock has increased by 3.74% since.

Directors and Officers Recent Trades:

  • COO Andrew Craig Miller sold 5,000 shares of KRTX stock on 01/11/2021 at the average price of $105.11. The price of the stock has increased by 3.13% since.

  • Director Atul Pande sold 5,714 shares of KRTX stock on 12/14/2020 at the average price of $92.64. The price of the stock has increased by 17.01% since.

For the complete insider trading history of KRTX, click here

.This article first appeared on GuruFocus.